Ono Pharmaceutical Co., Ltd. (TYO:4528)
1,661.00
-4.00 (-0.24%)
Aug 22, 2025, 3:30 PM JST
Ono Pharmaceutical Revenue
Ono Pharmaceutical had revenue of 127.54B JPY in the quarter ending June 30, 2025, with 8.38% growth. This brings the company's revenue in the last twelve months to 496.73B, down -0.72% year-over-year. In the fiscal year ending March 31, 2025, Ono Pharmaceutical had annual revenue of 486.87B, down -3.14%.
Revenue (ttm)
496.73B
Revenue Growth
-0.72%
P/S Ratio
1.57
Revenue / Employee
115.87M
Employees
4,287
Market Cap
780.29B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 486.87B | -15.80B | -3.14% |
Mar 31, 2024 | 502.67B | 55.49B | 12.41% |
Mar 31, 2023 | 447.19B | 85.83B | 23.75% |
Mar 31, 2022 | 361.36B | 52.08B | 16.84% |
Mar 31, 2021 | 309.28B | 16.86B | 5.77% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.21B |
Takeda Pharmaceutical Company | 4,480.25B |
Daiichi Sankyo Company | 1,924.68B |
HOYA Corporation | 876.09B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |
Ono Pharmaceutical News
- 18 days ago - Ono Pharmaceutical Co., Ltd. 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 18 days ago - Ono Pharmaceutical Co., Ltd. (OPHLF) Q1 FY2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Vertex and Ono Pharmaceutical form exclusive alliance for Povetacicept in Japan and South Korea - Seeking Alpha
- 2 months ago - Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea - Benzinga
- 2 months ago - Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea - Business Wire
- 3 months ago - Ono Pharmaceutical Co., Ltd. 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Ono Pharmaceutical reports FY results - Seeking Alpha
- 5 months ago - What's Going On With Cue Biopharma Shares Tuesday? - Benzinga